Skip to content
Andrew Lewis Law
  • Home
  • What We Do
  • Why Choose Us
  • Publications
  • About
  • Contact Us
LatestPublications

September 2018

Posted 31/03/201920/04/2021 Andrew

Advised the investor consortium in relation to their NZ$15m investment in leading medical cannabis start-up, Helius Therapeutics.

Post navigation

⟵Welcome to Andrew Lewis Law
The company or the assets?⟶
  • Home
  • What We Do
  • Why Choose Us
  • Publications
  • About
  • Contact Us
Website by  
Proudly powered by WordPress | Theme: Sydney by aThemes.